Case Summary (G.R. No. 138060)
Key Dates and Chronology (medical and procedural)
Initial consult with Dr. TuaAo: 2 September 1988. Series of follow‑ups and medication changes (September–December 1988). Acute loss of vision and elevated intraocular pressure (IOP) first documented 13 December 1988. Referral to glaucoma specialist and further evaluations late December 1988. Laser trabeculoplasty procedures in May 1990 and June 1991. Civil complaint filed 1 September 1992. RTC decision: 14 July 2000. Court of Appeals decision: 27 September 2006; resolution denying reconsideration: 3 July 2007. Supreme Court decision: April 21, 2009.
Applicable law and procedural standard
Primary legal authorities relied upon in the adjudication include the 1987 Philippine Constitution (applicable because the decision date is later than 1990), Rule 45 of the Rules of Court (governing petitions for review on certiorari), Article 2176 (quasi‑delict liability) of the Civil Code, and the Rules of Evidence and Civil Procedure (including requirements for preponderance of evidence and expert testimony in medical negligence cases).
Factual background and course of treatment
Peter sought treatment for “sore eyes” and conjunctivitis in early September 1988. Dr. TuaAo performed routine ocular examinations and initially prescribed Spersacet‑C. Subsequent developments included epidemic keratoconjunctivitis (EKC) and repeated prescriptions of steroid‑containing topical agents (Maxitrol and, when unavailable, Blephamide) over several weeks to months with tapering instructions and periodic follow‑ups. Fatima read the Maxitrol literature warning that prolonged steroid use may produce elevated IOP and glaucoma and that IOP should be routinely monitored if used ten days or longer.
Acute deterioration and specialist referral
By 13 December 1988 Peter presented with severe symptoms and documented elevated IOP (right eye 39 mm Hg; left 17 mm Hg) measured by tonometer. Dr. TuaAo discontinued Maxitrol, prescribed systemic and topical glaucoma medications (Diamox and Normoglaucon), and ordered close monitoring. Persistent elevated IOP and complex therapeutic considerations (recurrent EKC versus steroid‑induced IOP elevation) led to referral to glaucoma specialist Dr. Manuel Agulto on 28 December 1988. Dr. Agulto’s tests reflected significant glaucomatous damage (large cup‑to‑disc ratio) and recommended baseline visual fields, stepped medical therapy (including timolol), and possible trabeculoplasty if further loss occurred. Visual field testing later demonstrated tubular vision in the right eye. Peter subsequently underwent two laser trabeculoplasty procedures (May 1990; June 1991).
Petitioners’ allegations and claimed damages
Plaintiffs alleged steroid‑induced glaucoma caused by prolonged topical steroid use as prescribed by Dr. TuaAo without appropriate monitoring, resulting in permanent visual impairment (right eye), continuing need for medical supervision, diminished earning capacity, emotional and familial consequences, and various non‑pecuniary harms. The complaint sought compensatory, actual, moral and exemplary damages, and attorney’s fees.
Respondent’s defenses
Dr. TuaAo denied culpable negligence. He asserted (a) steroid‑induced IOP elevation is a recognized, often temporary risk; (b) he did not continuously prescribe steroids for an unreasonable or unmonitored period—Maxitrol was discontinued when EKC resolved and resumed only when EKC recurred; (c) he performed routine ocular examinations, including palpation to monitor tension, at each follow‑up; and (d) the clinical picture and optic nerve damage were consistent with pre‑existing or long‑standing open‑angle glaucoma unmasked, not caused, by steroid therapy.
Trial court findings (RTC)
The RTC dismissed the complaint for insufficiency of evidence. The trial court emphasized petitioners’ failure to present expert medical testimony to (1) establish the applicable standard of care for an ophthalmologist treating EKC with steroid combinations; (2) demonstrate that Dr. TuaAo deviated from that standard; and (3) prove causation linking the steroid therapy to Peter’s glaucoma. The RTC accepted respondent’s explanation that the steroids may have revealed an underlying glaucoma and found no contrary medical evidence in the record.
Court of Appeals’ ruling
The Court of Appeals affirmed the RTC. It underscored petitioners’ omission of expert proof that the prescriptions were improper and of medical testimony that palpation was an insufficient method for IOP monitoring. The appellate court also noted inadmissibility of alleged statements by Dr. Agulto because he was not presented as a witness and therefore such remarks amounted to hearsay when relayed through Peter. The appellate court gave weight to Dr. TuaAo’s uncontradicted testimony regarding his routine examinations and judgment.
Issues presented on review and standard of review
The Supreme Court identified the narrow issue as whether the Court of Appeals gravely erred in affirming the dismissal for insufficiency of evidence. The Court reaffirmed that under Rule 45 only questions of law are generally reviewable; findings of fact normally receive finality. An exception exists if a finding of fact is based on the alleged absence of evidence but the record contradicts that finding. The Court examined whether the record supported petitioners’ claim and whether the exception applied. Ultimately, because the dispute primarily involved factual questions of negligence and causation, the high court deferred to lower courts absent a clear legal error.
Legal standards for medical negligence and evidentiary requirements
The Court reiterated the four essential elements of liability in medical malpractice grounded on Article 2176: duty, breach, injury, and proximate causation. It emphasized that establishing the standard of care and causation in medical malpractice typically requires expert testimony from practitioners in the same field and locality, because such matters are technical and beyond the knowledge of laypersons. Proof of breach and causation must meet the preponderance‑of‑evidence standard and, where medical probability is required, must be supported by competent expert opinion rather than speculation.
Analysis of petitioners’ evidentiary shortcomings
The Supreme Court found petitioners failed to present any expert medical witness at trial to define the standard of care, to demonstrate deviation by Dr. TuaAo, or to establish with reasonable medical probability that the steroid therapy caused the glaucoma. Petitioners’ attempt to rely on respondent’s own testimony as an implicit admission of negligence was rejected: respondent’s testimony explained his diagnostic and
...continue readingCase Syllabus (G.R. No. 138060)
Procedural Posture
- Petition for review on certiorari under Rule 45 of the Revised Rules of Court (G.R. No. 178763), seeking reversal of: (a) the 27 September 2006 Decision and (b) the 3 July 2007 Resolution of the Court of Appeals in CA-G.R. CV No. 68666, which affirmed the 14 July 2000 Decision of the Regional Trial Court (RTC), Branch 150, Makati City (docketed as Civil Case No. 92-2482).
- Petitioners: Peter Paul Patrick Lucas, Fatima Gladys Lucas, Abbeygail Lucas and Gillian Lucas (plaintiffs below).
- Respondent: Dr. Prospero Ma. C. TuaAo (defendant below).
- RTC dismissed the complaint for insufficiency of evidence on 14 July 2000; Court of Appeals affirmed on 27 September 2006 and denied petitioners’ motion for reconsideration on 3 July 2007.
- Supreme Court (Third Division, decision penned by Justice Chico-Nazario) denied the petition for lack of merit and affirmed the Court of Appeals’ decisions; concurrence by Ynares-Santiago (Chairperson), Austria-Martinez, Nachura, and Peralta, JJ.
Facts — Initial Presentation and Referral
- Sometime in August 1988 petitioner Peter contracted “sore eyes” in his right eye; on 2 September 1988 he used Philamcare insurance for a consult.
- Philamcare Coordinator Dr. Edwin Oca referred Peter to Dr. Prospero Ma. C. TuaAo, an ophthalmologist at St. Luke’s Medical Center.
- On first consultation with Dr. TuaAo, Peter reported nine days since onset and that he was already taking Maxitrol.
- Dr. TuaAo performed an “ocular routine examination” comprising: gross external eye/extraconal examination; measurement of visual acuity; palpation to check intraocular pressure (IOP); observation of ocular motility; and ophthalmoscopy.
- Diagnosis by Dr. TuaAo on that consult: conjunctivitis (“sore eyes”); prescription: Spersacet-C eye drops; instruction to return for follow-up after one week.
Facts — Subsequent Visits, Diagnoses and Treatments (September–December 1988)
- 9 September 1988: follow-up — Dr. TuaAo reported the initial “sore eyes” had cleared; nonetheless Peter developed Epidemic Keratoconjunctivitis (EKC); Dr. TuaAo prescribed Maxitrol (steroid-based eye drop) at six (6) drops per day. Peter had already been using Maxitrol prior to his first consult with Dr. TuaAo.
- 21 September 1988: instructed to taper down Maxitrol because EKC had resolved; explicit caution that Maxitrol, being a steroid, must be withdrawn gradually to avoid recurrence.
- 6 October 1988: Peter complained of foreign-body sensation; Dr. TuaAo found EKC again and instructed resumption of Maxitrol at six drops per day; Maxitrol was out of stock that day.
- 6 October 1988 (subsequent): Dr. TuaAo substituted Blephamide (a steroid-based medication of lower concentration) with dosing: three (3) times a day for five (5) days; two (2) times a day for five (5) days; then once daily.
- 18 October 1988: Peter presented with severe eye pain, headache and blurred vision; EKC present; instructed to resume maximum dosage of Blephamide.
- 4 November 1988: examination showed EKC only at the periphery of the right eye; lower dosage of Blephamide prescribed.
- 26 November 1988: Peter returned complaining of “feeling worse” and EKC appeared to have spread to the whole right eye; Dr. TuaAo instructed resumption of Maxitrol; petitioners allege Peter mentioned the Maxitrol warning literature and was allegedly reassured by Dr. TuaAo.
Facts — Presentation of Elevated IOP and Subsequent Management (December 1988–January 1989)
- Early December 1988: Peter complained of progressive pain; on 13 December 1988 he awoke with no vision in his right eye; Fatima observed the right eye to be bloody and swollen; they rushed to Dr. TuaAo’s clinic.
- 13 December 1988: Dr. TuaAo noted hardness of the right eye; tonometer readings: right eye IOP 39.0 mm Hg, left eye 17.0 mm Hg (normal range given as 10.0–21.0 mm Hg); Dr. TuaAo ordered immediate discontinuance of Maxitrol and prescribed Diamox (acetazolamide) and Normoglaucon (metipranolol), with daily check-ups to monitor IOP.
- 15 December 1988: right-eye IOP measured at 21.0 mm Hg (high normal); Diamox continued but later discontinued when Peter complained of stomach pains and tingling in fingers.
- 21 December 1988: Peter sought second opinion with Dr. Ramon T. Batungbacal, who diagnosed glaucoma O.D. and recommended laser trabeculoplasty.
- 23 December 1988: returned to Dr. TuaAo; tonometer measured right-eye IOP at 41.0 mm Hg; Diamox and Normoglaucon resumed.
- 28 December 1988: Dr. TuaAo observed recurrence of EKC but IOP remained high; he referred Peter to glaucoma specialist Dr. Manuel B. Agulto for evaluation and possible management.
Facts — Specialist Evaluation and Tests (Late December 1988–January 1989)
- Dr. Agulto’s evaluation (29 December 1988) findings and recommendations (letter to Dr. TuaAo):
- Visual acuity: 20/25 R and 20/20 L; tension curve 19 R and 15 L on medications; slit-lamp: subepithelial corneal defect outer OD; circumferential peripheral iris atrophy OD; lenses clear; funduscopy: vertical cup-to-disc 0.85 R and 0.6 L with temporal slope R>L; Zeiss gonioscopy: basically open angles both eyes with occasional peripheral anterior synechiae OD.
- Opinion: Peter had sustained significant glaucoma damage; suggested baseline visual fields and medication push to lowest possible levels; proposed Timolol BID OD in lieu of Normoglaucon, consider dipivefrin (D’epifrin) if inadequate, and retention of Diamox or similar CAI; consider trabeculoplasty if further field loss in about three months.
- 31 December 1988: Peter presented Dr. Agulto’s letter to Dr. TuaAo; IOPs measured at 21.0 (R) and 17.0 (L); prescription for Timolol B.I.D. given but Timolol unavailable; Diamox and Normoglaucon continued.
- 2 January 1989: right-eye IOP at 21.0 mm Hg after being off Diamox for three days.
- 4 January 1989: visual field study by Dr. TuaAo revealed tubular vision in the right eye; IOP rose to 41.0 mm Hg in two days while Timolol and D’epifrin remained unavailable.
- January 1989 follow-ups: Peter complied with regular IOP monitoring on 7th, 13th, 16th and 20th January 1989.
- 13 January 1989: Peter consulted Dr. Jaime Lapuz who referred him to Dr. Mario V. Aquino, glaucoma specialist; Dr. Aquino later reportedly advised that Peter’s eyes were relatively normal except for right eye’s maximum borderline tension and confirmed tubular vision; advised lifetime medication and follow-ups.
- May 1990 and June 1991: Peter underwent two procedures of laser trabeculoplasty to attempt control of high IOP in the right eye.
Parties’ Claims and Relief Sought
- Petitioners’ core allegation: Peter suffered steroid-induced glaucoma as a direct consequence of prolonged use of Maxitrol prescribed by Dr. TuaAo; the prolonged steroid use caused elevation of IOP and impairment of vision that is incurable and may lead to total blindness.
- Alleged damages and consequences claimed by petitioners:
- Physical pain and suffering; lifetime medical supervision; two laser surgeries with possible future surgeries; impairment of sports-casting career and lost opportunities (e.g., declined assignments to cover Olympics and Asian Games); reduced anticipated income and limited capacity; chronic symptoms (headaches, nausea, dizziness, heart palpitations, rashes, chronic rhinitis, sinusitis); strained familial relations and need for wife (Fatima) to become breadwinner; deprivation of children’s opportunities; fear of total blindness.
- Specific monetary prayers in Amended Complaint:
- P2,000,000 to Peter as compensation for impaired vision.
- P300,000 to spouses Lucas as actual damages plus additional amounts proven.
- P1,000,000 as moral damages.
- P500,000 as exemplary damages.
- P200,000 as attorney’s fees plus costs of suit.
Respondent’s Defense and Explanation
- Dr. TuaAo’s principal defenses:
- No causal connection between treatments more than three years prior and Peter’s present glauco